Short-Term Debt to Capital: AtriCure Inc (ATRC)

The price history on the AtriCure, Inc. (ATRC) chart demonstrates the company's dynamics, where management relies on the transparency of clinical trials and expertise in physician training. High capital expenditures for certification and years of research create a powerful moat for the business. A stable cash flow is ensured by recognized cardiac surgery methods, with the indicator standing at 0.00, supporting maximum operating profit.

When constructing a long-term portfolio, financial stability screening requires assessing the ratio of short-term liabilities to equity to determine liquidity risks. This metric measures a company's dependence on rapid debt repayment, which for AtriCure, Inc. (ATRC) is offset by a steady cash flow from the sale of high-margin consumables, as captured on the short-term debt-to-equity chart.